Plus Therapeutics (PSTV) announces that the Company received notice of an additional advance payment from the Cancer Prevention and Research Institute of Texas. This $1.9M payment is part of the Company’s previously awarded $17.6M grant and is the second non-dilutive financing received from CPRIT following the $1.6M receipt announced in July 2025.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PSTV:
- Plus Therapeutics announces accreditation, certification for CNSide Diagnostics
- Plus Therapeutics upgraded to Buy from Hold at D. Boral Capital
- Plus Therapeutics regains compliance with applicable Nasdaq listing criteria
- Plus Therapeutics Secures Nasdaq Compliance Extension
- Plus Therapeutics price target lowered to $3 from $4 at Maxim